- Home
- MRBK vs KOD Comparison
MRBK vs KOD Comparison
Compare MRBK & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRBK
- KOD
- Stock Information
- Founded
- MRBK 2004
- KOD 2009
- Country
- MRBK United States
- KOD United States
- Employees
- MRBK N/A
- KOD N/A
- Industry
- MRBK Major Banks
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MRBK Finance
- KOD Health Care
- Exchange
- MRBK Nasdaq
- KOD Nasdaq
- Market Cap
- MRBK 159.8M
- KOD 186.3M
- IPO Year
- MRBK 2017
- KOD 2018
- Fundamental
- Price
- MRBK $14.39
- KOD $5.76
- Analyst Decision
- MRBK Buy
- KOD Hold
- Analyst Count
- MRBK 2
- KOD 5
- Target Price
- MRBK $16.00
- KOD $3.50
- AVG Volume (30 Days)
- MRBK 16.6K
- KOD 420.1K
- Earning Date
- MRBK 10-24-2024
- KOD 11-26-2024
- Dividend Yield
- MRBK 3.52%
- KOD N/A
- EPS Growth
- MRBK N/A
- KOD N/A
- EPS
- MRBK 1.00
- KOD N/A
- Revenue
- MRBK $92,357,000.00
- KOD N/A
- Revenue This Year
- MRBK N/A
- KOD N/A
- Revenue Next Year
- MRBK $11.13
- KOD N/A
- P/E Ratio
- MRBK $14.23
- KOD N/A
- Revenue Growth
- MRBK N/A
- KOD N/A
- 52 Week Low
- MRBK $8.26
- KOD $2.19
- 52 Week High
- MRBK $14.45
- KOD $7.77
- Technical
- Relative Strength Index (RSI)
- MRBK 71.68
- KOD 80.37
- Support Level
- MRBK $14.00
- KOD $5.08
- Resistance Level
- MRBK $14.29
- KOD $6.00
- Average True Range (ATR)
- MRBK 0.21
- KOD 0.36
- MACD
- MRBK -0.01
- KOD 0.07
- Stochastic Oscillator
- MRBK 87.50
- KOD 96.35
About MRBK Meridian Corporation
Meridian Corp is a full-service, state-chartered commercial bank providing personal, business lending, and deposit services. It operates in three business segments including Bank, Wealth, and Mortgage. It generates maximum revenue from the Bank segment that consists of commercial and retail banking. It generates interest income from its lending (including leasing) and investing activities and is dependent on the gathering of lower-cost deposits from its branch network or borrowed funds from other sources for funding its loans, resulting in the generation of net interest income, and other sources.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.